TBIO - T-Capital Biotechnology (RU000A102EK1)

At the current moment The Providers aim is to sell Funds assets at the best available price for partial share redemption. The Fund may hold only its assets at the date of registration of a change the Funds type to a closed-end mutual fund, assets included in the Fund in the process of blocked assets exchange, cash in rubles and foreign currencies in accounts and deposits in Russian credit institutions and foreign banks, deposit certificates of Russian credit institutions and foreign banks, government securities of the Russian Federation and foreign states, claims to a credit institution to pay the cash equivalent of precious metals at the current exchange rate, bonds of Russian legal entities that have obligations related to eurobonds of foreign organizations, as well as assets related to Fund management.

The T-Capital Biotechnology is a(n) Multi Asset Closed-End Investment Funds (CIF) seeks to invest in Undefined sector located in Global. The T-Capital fund’s base currency is USD and the share class was registered 04.12.2020 with unique ISIN - RU000A102EK1. Main exchange is Moscow Exchange T+ and ticker symbol is TBIO. The total expense ratio is 0.79%. The T-Capital Biotechnology pays dividends 0 time(s) per year.